Hepatitis A - Revision history

Ostermayer: Prepared the page for translation

2026-01-04T22:59:39Z

Prepared the page for translation

← Older revision		Revision as of 22:59, 4 January 2026
Line 1:		Line 1:
			<languages/>
			<translate>

	==Background==		==Background==

	*Transmission by		*Transmission by
	**Fecal-oral route		**Fecal-oral route
	**Most commonly transmitted from asymptomatic children to adults		**Most commonly transmitted from asymptomatic children to adults
	**Can also occur with improper food handling, oyster consumption		**Can also occur with improper food handling, oyster consumption


	==Clinical Features==		==Clinical Features==

	[[File:Jaundice eye.jpg\|thumb\|Jaundice from Hepatitis A.]]		[[File:Jaundice eye.jpg\|thumb\|Jaundice from Hepatitis A.]]
	*Incubation period 15-50 days		*Incubation period 15-50 days
	*Prodrome of [[nausea/vomiting]], malaise		*Prodrome of [[Special:MyLanguage/nausea/vomiting\|nausea/vomiting]], malaise
	**~1 week into illness, may have dark urine (bilirubinuria), clay-colored stools, [[jaundice]]		**~1 week into illness, may have dark urine (bilirubinuria), clay-colored stools, [[Special:MyLanguage/jaundice\|jaundice]]
	*No chronic component		*No chronic component
	*Can cause aversion to tobacco among smokers		*Can cause aversion to tobacco among smokers
	*~1-2% of HAV infections in adults lead to fulminant [[hepatic failure]]		*~1-2% of HAV infections in adults lead to fulminant [[Special:MyLanguage/hepatic failure\|hepatic failure]]
	*Death from [[hepatic failure]] is rare		*Death from [[Special:MyLanguage/hepatic failure\|hepatic failure]] is rare


	==Differential Diagnosis==		==Differential Diagnosis==

			</translate>
	{{Acute hepatitis causes}}		{{Acute hepatitis causes}}
			<translate>


	==Evaluation==		==Evaluation==

	[[File:Hepatitis A serology.jpg\|thumb\|Hepatitis A serology.]]		[[File:Hepatitis A serology.jpg\|thumb\|Hepatitis A serology.]]
			</translate>
	{{Acute hepatitis panel}}		{{Acute hepatitis panel}}
			<translate>


	==Management==		==Management==

	*Supportive care		*Supportive care
	**[[Antiemetics]]		**[[Special:MyLanguage/Antiemetics\|Antiemetics]]
	**[[oral rehydration therapy\|Oral]] or [[IVF\|IV hydration]]		**[[Special:MyLanguage/oral rehydration therapy\|Oral]] or [[Special:MyLanguage/IVF\|IV hydration]]
	**Avoid hepatotoxic medications		**Avoid hepatotoxic medications
	*Patients with fulminant hepatic failure (1-2% of HAV infections) may be considered for liver transplant		*Patients with fulminant hepatic failure (1-2% of HAV infections) may be considered for liver transplant
	*Postexposure prophylaxis recommend for non-immunized close contacts of patient		*Postexposure prophylaxis recommend for non-immunized close contacts of patient


	==Disposition==		==Disposition==

	*Typically discharge, admit if:		*Typically discharge, admit if:
	**INR >2		**INR >2
Line 36:		Line 54:
	**Intractable pain		**Intractable pain
	**Bilirubin >30		**Bilirubin >30
	**[[Hypoglycemia]]		**[[Special:MyLanguage/Hypoglycemia\|Hypoglycemia]]
	**Significant comorbidity/immunocompromised		**Significant comorbidity/immunocompromised


	==See Also==		==See Also==
	*[[Acute hepatitis]]
			*[[Special:MyLanguage/Acute hepatitis\|Acute hepatitis]]


	==External Links==		==External Links==


	==References==		==References==

	<references/>		<references/>

	[[Category:ID]]		[[Category:ID]]
	[[Category:GI]]		[[Category:GI]]
			</translate>

Rossdonaldson1: /* Clinical Features */

2024-02-28T20:34:45Z

Clinical Features

← Older revision		Revision as of 20:34, 28 February 2024
Line 6:		Line 6:

	==Clinical Features==		==Clinical Features==
	[[File:~~Jaundice08~~.jpg\|thumb\|Jaundice ~~of the skin]]~~		[[File:Jaundice eye.jpg\|thumb\|Jaundice from Hepatitis A.]]
	~~[[File:Jaundice.jpg\|thumb\|Pediatric jaundice with icterus of sclera~~.]]
	*Incubation period 15-50 days		*Incubation period 15-50 days
	*Prodrome of [[nausea/vomiting]], malaise		*Prodrome of [[nausea/vomiting]], malaise

Rossdonaldson1: /* Clinical Features */

2024-02-28T20:25:31Z

Clinical Features

← Older revision		Revision as of 20:25, 28 February 2024
Line 6:		Line 6:

	==Clinical Features==		==Clinical Features==
			[[File:Jaundice08.jpg\|thumb\|Jaundice of the skin]]
			[[File:Jaundice.jpg\|thumb\|Pediatric jaundice with icterus of sclera.]]
	*Incubation period 15-50 days		*Incubation period 15-50 days
	*Prodrome of [[nausea/vomiting]], malaise		*Prodrome of [[nausea/vomiting]], malaise

Rossdonaldson1: /* Evaluation */

2024-02-28T20:25:08Z

Evaluation

← Older revision		Revision as of 20:25, 28 February 2024
Line 18:		Line 18:

	==Evaluation==		==Evaluation==
			[[File:Hepatitis A serology.jpg\|thumb\|Hepatitis A serology.]]
	{{Acute hepatitis panel}}		{{Acute hepatitis panel}}

Elcatracho: /* Clinical Features */

2021-03-01T20:24:50Z

Clinical Features

← Older revision		Revision as of 20:24, 1 March 2021
Line 10:		Line 10:
	**~1 week into illness, may have dark urine (bilirubinuria), clay-colored stools, [[jaundice]]		**~1 week into illness, may have dark urine (bilirubinuria), clay-colored stools, [[jaundice]]
	*No chronic component		*No chronic component
			*Can cause aversion to tobacco among smokers
	*~1-2% of HAV infections in adults lead to fulminant [[hepatic failure]]		*~1-2% of HAV infections in adults lead to fulminant [[hepatic failure]]
	*Death from [[hepatic failure]] is rare		*Death from [[hepatic failure]] is rare

ClaireLewis at 21:03, 29 September 2019

2019-09-29T21:03:25Z

← Older revision		Revision as of 21:03, 29 September 2019
Line 11:		Line 11:
	*No chronic component		*No chronic component
	*~1-2% of HAV infections in adults lead to fulminant [[hepatic failure]]		*~1-2% of HAV infections in adults lead to fulminant [[hepatic failure]]
	*Death from hepatic failure is rare		*Death from [[hepatic failure]] is rare

	==Differential Diagnosis==		==Differential Diagnosis==
Line 22:		Line 22:
	*Supportive care		*Supportive care
	**[[Antiemetics]]		**[[Antiemetics]]
	**Oral or IV hydration		**[[oral rehydration therapy\|Oral]] or [[IVF\|IV hydration]]
	**Avoid hepatotoxic medications		**Avoid hepatotoxic medications
	*Patients with fulminant hepatic failure (1-2% of HAV infections) may be considered for liver transplant		*Patients with fulminant hepatic failure (1-2% of HAV infections) may be considered for liver transplant

ClaireLewis at 14:59, 18 August 2019

2019-08-18T14:59:15Z

← Older revision		Revision as of 14:59, 18 August 2019
Line 28:		Line 28:

	==Disposition==		==Disposition==
			*Typically discharge, admit if:
			**INR >2
			**Unable to tolerate PO
			**Intractable pain
			**Bilirubin >30
			**[[Hypoglycemia]]
			**Significant comorbidity/immunocompromised

	==See Also==		==See Also==

Neil.m.young at 14:54, 5 October 2016

2016-10-05T14:54:29Z

← Older revision		Revision as of 14:54, 5 October 2016
Line 1:		Line 1:
	==Background==		==Background==
	*Transmission		*Transmission by
	**Fecal-oral route		**Fecal-oral route
	**Most commonly transmitted from asymptomatic children to adults		**Most commonly transmitted from asymptomatic children to adults
Line 21:		Line 21:
	==Management==		==Management==
	*Supportive care		*Supportive care
	**[[~~antiemetics~~]]		**[[Antiemetics]]
	**~~oral~~ or IV hydration		**Oral or IV hydration
	**~~avoid~~ hepatotoxic medications		**Avoid hepatotoxic medications
	*Patients with fulminant hepatic failure (1-2% of HAV infections) may be considered for liver transplant		*Patients with fulminant hepatic failure (1-2% of HAV infections) may be considered for liver transplant
	*Postexposure prophylaxis recommend for non-immunized close contacts of patient		*Postexposure prophylaxis recommend for non-immunized close contacts of patient

ClaireLewis at 21:51, 28 September 2016

2016-09-28T21:51:29Z

← Older revision		Revision as of 21:51, 28 September 2016
Line 1:		Line 1:
	==Background==		==Background==

	~~==Clinical Features==~~
	*Transmission		*Transmission
	**Fecal-oral route		**Fecal-oral route
	**Most commonly transmitted from asymptomatic children to adults		**Most commonly transmitted from asymptomatic children to adults
	**Can also occur with improper food handling, oyster consumption		**Can also occur with improper food handling, oyster consumption
	*Clinical ~~course~~
	**Incubation period 15-50 days		==Clinical Features==
	**Prodrome of nausea, vomiting, malaise		*Incubation period 15-50 days
	**~~~1wk~~ into illness, may have dark urine (bilirubinuria), clay-colored stools, jaundice		*Prodrome of [[nausea/vomiting]], malaise
			**~1 week into illness, may have dark urine (bilirubinuria), clay-colored stools, [[jaundice]]
	*No chronic component		*No chronic component
	*~1-2% of HAV infections in adults lead to fulminant hepatic failure		*~1-2% of HAV infections in adults lead to fulminant [[hepatic failure]]
	*Death from hepatic failure is rare		*Death from hepatic failure is rare

Line 22:		Line 21:
	==Management==		==Management==
	*Supportive care		*Supportive care
	**antiemetics		**[[antiemetics]]
	**oral or IV hydration		**oral or IV hydration
	**avoid hepatotoxic medications		**avoid hepatotoxic medications

Kaoru: /* Clinical Features */

2016-09-28T18:11:36Z

Clinical Features

← Older revision		Revision as of 18:11, 28 September 2016
Line 11:		Line 11:
	**~1wk into illness, may have dark urine (bilirubinuria), clay-colored stools, jaundice		**~1wk into illness, may have dark urine (bilirubinuria), clay-colored stools, jaundice
	*No chronic component		*No chronic component
			*~1-2% of HAV infections in adults lead to fulminant hepatic failure
	*Death from hepatic failure is rare		*Death from hepatic failure is rare